Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

Ginkgo Bioworks announced today that it has been awarded a contract through the Biomedical Advanced Research and Development Authority's (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium ...

AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...

Prescient investors who participated in Immaterial’s £13.5million Series A2 funding round will be delighted that the advanced ...

Learn more about whether BioMarin Pharmaceutical Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

AWMA®, APMA®, CRPC®, AWMA®, ABFP®, investment advisor representative at Retirement Income Source® SFG, has been recognized by InvestmentNews as the Orion Award winner for Rising Star Advisor of ...

Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single ...

Prof Fairen-Jimenez, CSO of Vector Bioscience Cambridge and Professor of Molecular Engineering at the University of Cambridge ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

New CEO, CFO, and EVP of Life Science named to drive strategic execution across Diagnostics and Life Science. CINCINNATI, Oct. 14, 2025 /PRNewswire/ -- Meridian Bioscience, Inc., a leading global ...

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Oct 8, 2025 at 7:41 ...